Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-01 4:06 pm Purchase | 2021-12-31 | 13G | Roivant Sciences Ltd. ROIV | Sumitomo Chemical Co. Ltd. | 86,367,360 12.480% | 86,367,360 (New Position) | Filing History |
| 2021-10-20 5:13 pm Purchase | 2021-10-18 | 13D | Arbutus Biopharma Corporation ABUS | Roivant Sciences Ltd. ROIV | 38,847,462 29.100% | 22,833,922 (+142.59%) | Filing History |
| 2021-08-02 08:23 am Purchase | 2021-08-02 | 13D | Immunovant, Inc. IMVT | Roivant Sciences Ltd. ROIV | 73,398,664 63.800% | 17,021,276 (+30.19%) | Filing History |
| 2021-03-08 08:00 am Unchanged | 2021-03-08 | 13D | Immunovant, Inc. IMVT | Roivant Sciences Ltd. ROIV | 56,377,388 57.500% | 0 (Unchanged) | Filing History |